Crenolanib is a potent inhibitor of PDGFR (Kd for alpha = 2.1 nM, ß = 3.2 nM) and FLT3 (Kd = 0.74 nM).1 Crenolanib is a type I inhibitor binding only to the active kinase conformation. It showed potent activity against imatinib-resistant PDGFRalpha mutations D84
* VAT and and shipping costs not included. Errors and price changes excepted